Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2003;41:1000-1005
Published online before print March 31, 2003, doi: 10.1161/01.HYP.0000066844.63035.3A
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
41/5/1000    most recent
01.HYP.0000066844.63035.3Av1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Strazzullo, P.
Right arrow Articles by Barba, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strazzullo, P.
Right arrow Articles by Barba, G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Hazardous Substances DB
*SODIUM
Related Collections
Right arrow Clinical Studies

(Hypertension. 2003;41:1000.)
© 2003 American Heart Association, Inc.


Brief Reviews

Altered Renal Handling of Sodium in Human Hypertension

Short Review of the Evidence

Pasquale Strazzullo; Ferruccio Galletti; Gianvincenzo Barba

From the Department of Clinical and Experimental Medicine, Unit of Clinical Genetics and Pharmacology, Hypertension and Mineral Metabolism, Federico II University of Naples Medical School (P.S., F.G.), Naples, Italy; and Epidemiology and Population Genetics, Institute of Food Science, National Research Council (G.B.), Avellino, Italy.

Correspondence to P. Strazzullo, MD, Department of Clinical and Experimental Medicine, "Federico II" University of Naples Medical School, Via S. Pansini, 5, 80131 Naples, Italy. E-mail strazzul{at}unina.it

A pathogenic role of the kidney in hypertension has been strongly supported by experimental studies by Guyton and Dahl since the 1960s. In the early 1980s, de Wardener and MacGregor proposed that in hypertensive patients the ability of the kidneys to excrete a sodium load could be genetically impaired. Since then, "sodium-sensitive" hypertension has been the object of numerous studies, mostly on animal models because of the difficulty to investigate the renal handling of sodium in humans. More recently, considerable progress in this field has been made thanks to the in vivo study of segmental renal tubular function by the clearance of lithium and to the growing knowledge of the genetics of renal tubular sodium transport systems. The scope of this review is to briefly review the most relevant information gathered by the investigation of segmental renal tubular sodium handling in humans as related to blood pressure regulation and hypertension. In aggregate, the results of these studies strongly support the association between altered renal sodium handling and high blood pressure and suggest a causal role of genetic, nutritional, metabolic, and neurohormonal factors. All of these factors, alone or in combination, may be able to impair the normal renal tubular sodium handling and influence blood pressure homeostasis. The paradigm of the pathogenic role of the kidney in hypertension is thus relentlessly shifting toward the definition of inherited as well as acquired renal tubular defects and molecular alterations, providing a plausible explanation for the alteration in blood pressure levels.


Key Words: sodium • kidney • hypertension, essential • hypertension, sodium-dependent • genetics




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
M. B. Butterworth, R. S. Edinger, R. A. Frizzell, and J. P. Johnson
Regulation of the epithelial sodium channel by membrane trafficking
Am J Physiol Renal Physiol, January 1, 2009; 296(1): F10 - F24.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
B. Rodriguez-Iturbe and N. D. Vaziri
Salt-sensitive hypertension--update on novel findings
Nephrol. Dial. Transplant., April 1, 2007; 22(4): 992 - 995.
[Full Text] [PDF]


Home page
HypertensionHome page
T. J. Wang, P. Gona, M. G. Larson, D. Levy, E. J. Benjamin, G. H. Tofler, P. F. Jacques, J. B. Meigs, N. Rifai, J. Selhub, et al.
Multiple Biomarkers and the Risk of Incident Hypertension
Hypertension, March 1, 2007; 49(3): 432 - 438.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Mate, A. Barfull, A. M. Hermosa, L. Gomez-Amores, C. M. Vazquez, and J. M. Planas
Regulation of sodium-glucose cotransporter SGLT1 in the intestine of hypertensive rats
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2006; 291(3): R760 - R767.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Ehmke
Neurogenic Mechanisms and Salt Sensitivity
Hypertension, December 1, 2005; 46(6): 1259 - 1260.
[Full Text] [PDF]


Home page
HypertensionHome page
M. H. Weinberger
More on the Sodium Saga
Hypertension, November 1, 2004; 44(5): 609 - 611.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
L. M. Ruilope
New European guidelines for management of hypertension: what is relevant for the nephrologist
Nephrol. Dial. Transplant., March 1, 2004; 19(3): 524 - 528.
[Full Text] [PDF]


Home page
HypertensionHome page
A. Siani, P. Russo, F. Paolo Cappuccio, R. Iacone, A. Venezia, O. Russo, G. Barba, L. Iacoviello, and P. Strazzullo
Combination of Renin-Angiotensin System Polymorphisms Is Associated With Altered Renal Sodium Handling and Hypertension
Hypertension, March 1, 2004; 43(3): 598 - 602.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. W. Sanders
Salt Intake, Endothelial Cell Signaling, and Progression of Kidney Disease
Hypertension, February 1, 2004; 43(2): 142 - 146.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. B. de Paula, A. A. da Silva, and J. E. Hall
Aldosterone Antagonism Attenuates Obesity-Induced Hypertension and Glomerular Hyperfiltration
Hypertension, January 1, 2004; 43(1): 41 - 47.
[Abstract] [Full Text] [PDF]